SCHEMBL9519797

SCHEMBL9519797

O=C(O)C/C=C\C=C(c1cccc(F)c1)c1cccc(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.47
CES1 P23141 2/20 0.47
PARP1 P09874 1/20 0.45
GPR52 Q9Y2T5 1/20 0.45
TBXAS1 P24557 1/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
PTAFR P25105 3/20 0.42
PLA2G7 Q13093 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
KCNK3 O14649 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
NPC1 O15118 3/20 0.39
HPGD P15428 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9520329 1.00 CES2 (0.47) CES2CES1PARP1GPR52TBXAS1
SCHEMBL9519518 0.89 NPC1 (0.54) CES2CES1PARP1GPR52PTAFR
SCHEMBL9520665 0.89 NPC1 (0.54) CES2CES1PARP1GPR52PTAFR
SCHEMBL9521627 0.82 PAM (0.50) CES2CES1PARP1TBXAS1PTAFR
SCHEMBL9520140 0.82 PAM (0.50) CES2CES1PARP1TBXAS1PTAFR
SCHEMBL9519281 0.82 ERCC5 (0.45) PARP1PTAFRMEN1KMT2AKCNK3
SCHEMBL9520834 0.82 ERCC5 (0.45) PARP1PTAFRMEN1KMT2AKCNK3
SCHEMBL9520579 0.81 CES2 (0.51) CES2TBXAS1KCNK3HPGDLMNA
SCHEMBL9519800 0.81 CES2 (0.51) CES2TBXAS1KCNK3HPGDLMNA
SCHEMBL9521054 0.81 CES2 (0.41) CES2CES1TBXAS1PTAFRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0299379-B1 PENTADIENAMIDE PAF-ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1993-04-21 EP disclosed
EP-0299379-A1 Pentadienamide PAF-antagonists F. HOFFMANN-LA ROCHE AG (CH) 1989-01-18 EP disclosed